Connect your AI

Biodesix, Inc. BDSX Prepaid & Other Current

Prepaid & Other Current at other companies

NeoGenomicsNEO

$175K-20.1%

VeracyteVCYT

$11.59M-34.8%

Adaptive BiotechnologiesADPT

$13.95M+29.2%

Personalis, Inc.PSNL

$5.03M+3.9%

Guardant HealthGH

$43.49M+21.6%

Tempus AI, Inc.TEM

$42.53M+1.1%

Other financials

Income statement

Revenue$25.6M+42.3%

Operating income-$6.2M+32.1%

Net income-$7.8M+29.8%

EPS (diluted)-$0.81+46.7%

Balance sheet

Cash & equivalents$25.6M+45.3%

Total debt$71.6M+15.0%

Total equity$9.1M-17.4%

Total assets$94.6M+9.7%

Cash flow

Operating cash flow-$10.2M-18.2%

CapEx$81.0K+9.5%

Free cash flow-$10.2M-18.1%

Valuation

Market cap$233.52M+462%

Enterprise value$279.56M+198%

P/S2.4×+1.9×

Profitability

Operating margin-26%-7.5pp

Net margin-33.3%-9.3pp

FCF margin-26.8%-9.6pp

Returns & leverage

Return on equity-316.5%—

Debt / equity7.8×+2.2×

Current ratio2.8×+0.6×

Where this comes from

Reported directly by Biodesix, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Biodesix, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Biodesix, Inc.'s prepaid & other current?: Biodesix, Inc. (BDSX) reported prepaid & other current of $5.84M in Q1 2026.
How has Biodesix, Inc.'s prepaid & other current changed year-over-year?: Biodesix, Inc.'s prepaid & other current increased by 33.3% year-over-year, from $4.38M to $5.84M.
What is the long-term trend for Biodesix, Inc.'s prepaid & other current?: Over 5 years (2020 to 2025), Biodesix, Inc.'s prepaid & other current has grown at a -12.4% compound annual growth rate (CAGR), from $8.71M to $4.5M.
What does prepaid & other current mean?: Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.